AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Aspirin + Paracetamol + Caffeine in Zambia
1 product registered with ZAMRA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Grand-Pa Headache Powders Powder sachets | 025/019 | GlaxoSmithKline South Africa (Pty) Ltd | active | 11 Jul 2030 |
Aspirin + Paracetamol + Caffeine — ZAMRA Registration Details
ZAMRA (Zambia) has 1 registered product containing Aspirin + Paracetamol + Caffeine, of which 1 is currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Aspirin + Paracetamol + Caffeine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.